Anna R. Giuliano

Anna R. Giuliano

Auto-generated profile, based on publicly available information

Anna R. Giuliano

Cancer Prevention and Control Division, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002
Verified
Journal Article
Closed access
RSRebecca L Sedjo
Rebecca L Sedjo
DRDenise J Roe
Denise J Roe
MAMartha Abrahamsen
Martha Abrahamsen
RHRobin B Harris
Robin B Harris
NCNeal Craft
Neal Craft
AGAnna R Giuliano
Anna R Giuliano

9 November 2006 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
ESErin M. Siegel
Erin M. Siegel
NCNeal E. Craft
Neal E. Craft
EDEliane Duarte‐Franco
Eliane Duarte‐Franco
LVLuisa L. Villa
Luisa L. Villa
EFEduardo Franco
Eduardo Franco
AGAnna R. Giuliano
Anna R. Giuliano
Although oncogenic HPV infections have been established as the necessary cause of cervical cancer, most HPV infections are transient and rarely progress to cervical lesions. Current research is focused on identifying factors associated with viral persistence and clearance, such as nutritional status. We evaluated the association between serum antioxidant nutrients (retinol, 10 carotenoids and 3 tocopherols) and type‐specific HPV persistence over 4 visits among 405 women participating in the Ludwig‐McGill cohort study. We measured circulating carotenoids and tocopherol at 4 different clinical visits for each woman. We report the results from different analytic approaches (a case–control approach at both the woman and viral level, and a prospective approach based on persistent events) that examined the association between these micronutrients and type‐specific oncogenic and nononcogenic HPV persistence. In the case–control analysis at the viral level, midcirculating levels of α‐tocopherol were inversely associated with nononcogenic HPV persistent infection (adjusted odds ratio (AOR) = 0.28, 95% CI 0.14–0.57), while high levels were marginally associated (AOR = 0.59, 95% CI 0.28–1.19). Similarly, utilizing generalized estimating equation models, circulating levels of α‐ and δ‐tocopherol in the middle or upper tertiles were inversely associated with type‐specific nononcogenic HPV persistence (AOR = 0.44, 95% CI 0.19–0.97 and AOR = 0.46, 95% CI 0.19–1.11, respectively). Our study among Brazilian women suggests that serum levels of tocopherols may be protective against nononcogenic HPV persistence. However, we did not find a strong protective effect (as hypothesized) of other serum antioxidant nutrients and type‐specific oncogenic HPV persistence measured over 4 clinical visits.